In contrast, in vivo we found that AZD2014 alone reduced H1993 clone 11 tumor growth by ~41% ± 8.9% s.e.m. (Figure 8C) which correlated with suppression of AKT activation (Figure 8D). This evidence concerns the gene AKT1 and neoplasm.